Rare Disease Trial, Recruiting NCT06399952 Sponsor: University of Missouri-Columbia Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT06399952
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Baker Gordon syndrome:

  • You have been diagnosed with Baker Gordon syndrome confirmed through genetic testing
  • You are between 0 and 99 years old
  • You are able to share your medical records and test results with the research team
  • You are able to complete tests and questionnaires as part of the study

For primary caregivers or legal representatives of participants:

  • You are 18 years old or older
  • You are the legal caregiver of someone diagnosed with Baker Gordon syndrome
  • You are willing to follow the study procedures, as agreed with the research team
  • You are willing to sign a consent form
  • You are able to understand all the information provided about the study, as confirmed by the research team

Who may not be able to join:

For people with Baker Gordon syndrome:

  • You have another condition (not related to Baker Gordon syndrome) that also affects brain development or development of the nervous system

For primary caregivers or legal representatives:

  • You are under 18 years old

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: W. David Arnold, MD, University of Missouri-Columbia

Phone: 573-884-2924

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Missouri-Columbia
Registry
ClinicalTrials.gov
Start date
30 April 2024
Est. completion
5 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Collection of relevant medical data (retrospective and prospective); Neurological Assessment Scale; Clinical Global Impressions Scale - Practitioner; Pediatric Evaluation of Disability Inventory; Pediatric Evaluation of Disability Inventory Computer Adaptive Test (PEDI-CAT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov